nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—Alkylating Activity—Chlorambucil—breast cancer	0.202	0.333	CiPCiCtD
Temozolomide—Alkylating Activity—Thiotepa—breast cancer	0.202	0.333	CiPCiCtD
Temozolomide—Alkylating Activity—Melphalan—breast cancer	0.202	0.333	CiPCiCtD
Temozolomide—CYP3A4—breast cancer	0.12	1	CbGaD
Temozolomide—CYP3A4—Exemestane—breast cancer	0.023	0.133	CbGbCtD
Temozolomide—CYP3A4—Letrozole—breast cancer	0.0196	0.113	CbGbCtD
Temozolomide—CYP3A4—Anastrozole—breast cancer	0.0174	0.101	CbGbCtD
Temozolomide—CYP3A4—Toremifene—breast cancer	0.0159	0.0921	CbGbCtD
Temozolomide—CYP3A4—Fulvestrant—breast cancer	0.0148	0.0856	CbGbCtD
Temozolomide—CYP3A4—Thiotepa—breast cancer	0.0132	0.0763	CbGbCtD
Temozolomide—CYP3A4—Ixabepilone—breast cancer	0.0121	0.0698	CbGbCtD
Temozolomide—CYP3A4—Lapatinib—breast cancer	0.0116	0.0672	CbGbCtD
Temozolomide—CYP3A4—Raloxifene—breast cancer	0.00882	0.0509	CbGbCtD
Temozolomide—CYP3A4—Vinorelbine—breast cancer	0.00645	0.0372	CbGbCtD
Temozolomide—CYP3A4—Tamoxifen—breast cancer	0.00582	0.0336	CbGbCtD
Temozolomide—CYP3A4—Mitoxantrone—breast cancer	0.00568	0.0328	CbGbCtD
Temozolomide—CYP3A4—Paclitaxel—breast cancer	0.00453	0.0262	CbGbCtD
Temozolomide—CYP3A4—Irinotecan—breast cancer	0.00447	0.0258	CbGbCtD
Temozolomide—CYP3A4—Vinblastine—breast cancer	0.00398	0.023	CbGbCtD
Temozolomide—CYP3A4—Docetaxel—breast cancer	0.00328	0.0189	CbGbCtD
Temozolomide—CYP3A4—Doxorubicin—breast cancer	0.00244	0.0141	CbGbCtD
Temozolomide—Musculoskeletal discomfort—Capecitabine—breast cancer	1.13e-05	0.000112	CcSEcCtD
Temozolomide—Flushing—Epirubicin—breast cancer	1.13e-05	0.000112	CcSEcCtD
Temozolomide—Cardiac disorder—Epirubicin—breast cancer	1.13e-05	0.000112	CcSEcCtD
Temozolomide—Vomiting—Fluorouracil—breast cancer	1.13e-05	0.000112	CcSEcCtD
Temozolomide—Dyspepsia—Docetaxel—breast cancer	1.12e-05	0.000112	CcSEcCtD
Temozolomide—Haemorrhage—Doxorubicin—breast cancer	1.12e-05	0.000112	CcSEcCtD
Temozolomide—Hepatitis—Doxorubicin—breast cancer	1.12e-05	0.000112	CcSEcCtD
Temozolomide—Insomnia—Capecitabine—breast cancer	1.12e-05	0.000111	CcSEcCtD
Temozolomide—Hypoaesthesia—Doxorubicin—breast cancer	1.12e-05	0.000111	CcSEcCtD
Temozolomide—Rash—Fluorouracil—breast cancer	1.12e-05	0.000111	CcSEcCtD
Temozolomide—Dermatitis—Fluorouracil—breast cancer	1.11e-05	0.000111	CcSEcCtD
Temozolomide—Pharyngitis—Doxorubicin—breast cancer	1.11e-05	0.000111	CcSEcCtD
Temozolomide—Paraesthesia—Capecitabine—breast cancer	1.11e-05	0.00011	CcSEcCtD
Temozolomide—Decreased appetite—Docetaxel—breast cancer	1.11e-05	0.00011	CcSEcCtD
Temozolomide—Hypersensitivity—Paclitaxel—breast cancer	1.11e-05	0.00011	CcSEcCtD
Temozolomide—Headache—Fluorouracil—breast cancer	1.11e-05	0.00011	CcSEcCtD
Temozolomide—Urinary tract disorder—Doxorubicin—breast cancer	1.11e-05	0.00011	CcSEcCtD
Temozolomide—Oedema peripheral—Doxorubicin—breast cancer	1.11e-05	0.00011	CcSEcCtD
Temozolomide—Dysgeusia—Methotrexate—breast cancer	1.1e-05	0.00011	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Docetaxel—breast cancer	1.1e-05	0.00011	CcSEcCtD
Temozolomide—Connective tissue disorder—Doxorubicin—breast cancer	1.1e-05	0.00011	CcSEcCtD
Temozolomide—Dyspnoea—Capecitabine—breast cancer	1.1e-05	0.00011	CcSEcCtD
Temozolomide—Fatigue—Docetaxel—breast cancer	1.1e-05	0.00011	CcSEcCtD
Temozolomide—Angiopathy—Epirubicin—breast cancer	1.1e-05	0.000109	CcSEcCtD
Temozolomide—Urethral disorder—Doxorubicin—breast cancer	1.1e-05	0.000109	CcSEcCtD
Temozolomide—Nausea—Mitoxantrone—breast cancer	1.1e-05	0.000109	CcSEcCtD
Temozolomide—Nausea—Irinotecan—breast cancer	1.1e-05	0.000109	CcSEcCtD
Temozolomide—Immune system disorder—Epirubicin—breast cancer	1.1e-05	0.000109	CcSEcCtD
Temozolomide—Mediastinal disorder—Epirubicin—breast cancer	1.09e-05	0.000109	CcSEcCtD
Temozolomide—Constipation—Docetaxel—breast cancer	1.09e-05	0.000109	CcSEcCtD
Temozolomide—Pain—Docetaxel—breast cancer	1.09e-05	0.000109	CcSEcCtD
Temozolomide—Back pain—Methotrexate—breast cancer	1.09e-05	0.000109	CcSEcCtD
Temozolomide—Dyspepsia—Capecitabine—breast cancer	1.09e-05	0.000108	CcSEcCtD
Temozolomide—Chills—Epirubicin—breast cancer	1.09e-05	0.000108	CcSEcCtD
Temozolomide—Visual impairment—Doxorubicin—breast cancer	1.08e-05	0.000108	CcSEcCtD
Temozolomide—Asthenia—Paclitaxel—breast cancer	1.08e-05	0.000108	CcSEcCtD
Temozolomide—Decreased appetite—Capecitabine—breast cancer	1.08e-05	0.000107	CcSEcCtD
Temozolomide—Alopecia—Epirubicin—breast cancer	1.07e-05	0.000107	CcSEcCtD
Temozolomide—Nausea—Gemcitabine—breast cancer	1.07e-05	0.000106	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Capecitabine—breast cancer	1.07e-05	0.000106	CcSEcCtD
Temozolomide—Fatigue—Capecitabine—breast cancer	1.07e-05	0.000106	CcSEcCtD
Temozolomide—Pruritus—Paclitaxel—breast cancer	1.07e-05	0.000106	CcSEcCtD
Temozolomide—Vision blurred—Methotrexate—breast cancer	1.06e-05	0.000106	CcSEcCtD
Temozolomide—Mental disorder—Epirubicin—breast cancer	1.06e-05	0.000106	CcSEcCtD
Temozolomide—Erythema multiforme—Doxorubicin—breast cancer	1.06e-05	0.000106	CcSEcCtD
Temozolomide—Constipation—Capecitabine—breast cancer	1.06e-05	0.000105	CcSEcCtD
Temozolomide—Pain—Capecitabine—breast cancer	1.06e-05	0.000105	CcSEcCtD
Temozolomide—Erythema—Epirubicin—breast cancer	1.06e-05	0.000105	CcSEcCtD
Temozolomide—Malnutrition—Epirubicin—breast cancer	1.06e-05	0.000105	CcSEcCtD
Temozolomide—Feeling abnormal—Docetaxel—breast cancer	1.05e-05	0.000105	CcSEcCtD
Temozolomide—Nausea—Fluorouracil—breast cancer	1.05e-05	0.000105	CcSEcCtD
Temozolomide—Eye disorder—Doxorubicin—breast cancer	1.05e-05	0.000104	CcSEcCtD
Temozolomide—Ill-defined disorder—Methotrexate—breast cancer	1.05e-05	0.000104	CcSEcCtD
Temozolomide—Tinnitus—Doxorubicin—breast cancer	1.05e-05	0.000104	CcSEcCtD
Temozolomide—Gastrointestinal pain—Docetaxel—breast cancer	1.04e-05	0.000104	CcSEcCtD
Temozolomide—Anaemia—Methotrexate—breast cancer	1.04e-05	0.000104	CcSEcCtD
Temozolomide—Flushing—Doxorubicin—breast cancer	1.04e-05	0.000104	CcSEcCtD
Temozolomide—Cardiac disorder—Doxorubicin—breast cancer	1.04e-05	0.000104	CcSEcCtD
Temozolomide—Dysgeusia—Epirubicin—breast cancer	1.03e-05	0.000103	CcSEcCtD
Temozolomide—Diarrhoea—Paclitaxel—breast cancer	1.03e-05	0.000103	CcSEcCtD
Temozolomide—Back pain—Epirubicin—breast cancer	1.02e-05	0.000102	CcSEcCtD
Temozolomide—Feeling abnormal—Capecitabine—breast cancer	1.02e-05	0.000101	CcSEcCtD
Temozolomide—Angiopathy—Doxorubicin—breast cancer	1.02e-05	0.000101	CcSEcCtD
Temozolomide—Malaise—Methotrexate—breast cancer	1.02e-05	0.000101	CcSEcCtD
Temozolomide—Immune system disorder—Doxorubicin—breast cancer	1.01e-05	0.000101	CcSEcCtD
Temozolomide—Vertigo—Methotrexate—breast cancer	1.01e-05	0.000101	CcSEcCtD
Temozolomide—Gastrointestinal pain—Capecitabine—breast cancer	1.01e-05	0.000101	CcSEcCtD
Temozolomide—Mediastinal disorder—Doxorubicin—breast cancer	1.01e-05	0.000101	CcSEcCtD
Temozolomide—Abdominal pain—Docetaxel—breast cancer	1.01e-05	0.0001	CcSEcCtD
Temozolomide—Body temperature increased—Docetaxel—breast cancer	1.01e-05	0.0001	CcSEcCtD
Temozolomide—Leukopenia—Methotrexate—breast cancer	1.01e-05	0.0001	CcSEcCtD
Temozolomide—Chills—Doxorubicin—breast cancer	1.01e-05	0.0001	CcSEcCtD
Temozolomide—Dizziness—Paclitaxel—breast cancer	9.97e-06	9.91e-05	CcSEcCtD
Temozolomide—Vision blurred—Epirubicin—breast cancer	9.95e-06	9.9e-05	CcSEcCtD
Temozolomide—Alopecia—Doxorubicin—breast cancer	9.92e-06	9.86e-05	CcSEcCtD
Temozolomide—Cough—Methotrexate—breast cancer	9.84e-06	9.79e-05	CcSEcCtD
Temozolomide—Mental disorder—Doxorubicin—breast cancer	9.83e-06	9.78e-05	CcSEcCtD
Temozolomide—Urticaria—Capecitabine—breast cancer	9.83e-06	9.77e-05	CcSEcCtD
Temozolomide—Ill-defined disorder—Epirubicin—breast cancer	9.8e-06	9.74e-05	CcSEcCtD
Temozolomide—Body temperature increased—Capecitabine—breast cancer	9.78e-06	9.73e-05	CcSEcCtD
Temozolomide—Abdominal pain—Capecitabine—breast cancer	9.78e-06	9.73e-05	CcSEcCtD
Temozolomide—Convulsion—Methotrexate—breast cancer	9.77e-06	9.72e-05	CcSEcCtD
Temozolomide—Erythema—Doxorubicin—breast cancer	9.77e-06	9.72e-05	CcSEcCtD
Temozolomide—Malnutrition—Doxorubicin—breast cancer	9.77e-06	9.72e-05	CcSEcCtD
Temozolomide—Anaemia—Epirubicin—breast cancer	9.76e-06	9.71e-05	CcSEcCtD
Temozolomide—Agitation—Epirubicin—breast cancer	9.7e-06	9.65e-05	CcSEcCtD
Temozolomide—Myalgia—Methotrexate—breast cancer	9.6e-06	9.55e-05	CcSEcCtD
Temozolomide—Arthralgia—Methotrexate—breast cancer	9.6e-06	9.55e-05	CcSEcCtD
Temozolomide—Vomiting—Paclitaxel—breast cancer	9.58e-06	9.53e-05	CcSEcCtD
Temozolomide—Dysgeusia—Doxorubicin—breast cancer	9.57e-06	9.52e-05	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.54e-06	9.49e-05	CcSEcCtD
Temozolomide—Malaise—Epirubicin—breast cancer	9.52e-06	9.47e-05	CcSEcCtD
Temozolomide—Rash—Paclitaxel—breast cancer	9.5e-06	9.45e-05	CcSEcCtD
Temozolomide—Dermatitis—Paclitaxel—breast cancer	9.49e-06	9.44e-05	CcSEcCtD
Temozolomide—Discomfort—Methotrexate—breast cancer	9.49e-06	9.44e-05	CcSEcCtD
Temozolomide—Vertigo—Epirubicin—breast cancer	9.49e-06	9.43e-05	CcSEcCtD
Temozolomide—Leukopenia—Epirubicin—breast cancer	9.45e-06	9.4e-05	CcSEcCtD
Temozolomide—Back pain—Doxorubicin—breast cancer	9.45e-06	9.4e-05	CcSEcCtD
Temozolomide—Headache—Paclitaxel—breast cancer	9.44e-06	9.39e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Docetaxel—breast cancer	9.41e-06	9.36e-05	CcSEcCtD
Temozolomide—Palpitations—Epirubicin—breast cancer	9.33e-06	9.28e-05	CcSEcCtD
Temozolomide—Confusional state—Methotrexate—breast cancer	9.28e-06	9.23e-05	CcSEcCtD
Temozolomide—Cough—Epirubicin—breast cancer	9.21e-06	9.16e-05	CcSEcCtD
Temozolomide—Anaphylactic shock—Methotrexate—breast cancer	9.21e-06	9.16e-05	CcSEcCtD
Temozolomide—Vision blurred—Doxorubicin—breast cancer	9.21e-06	9.16e-05	CcSEcCtD
Temozolomide—Asthenia—Docetaxel—breast cancer	9.17e-06	9.12e-05	CcSEcCtD
Temozolomide—Convulsion—Epirubicin—breast cancer	9.15e-06	9.1e-05	CcSEcCtD
Temozolomide—Infection—Methotrexate—breast cancer	9.15e-06	9.1e-05	CcSEcCtD
Temozolomide—Hypertension—Epirubicin—breast cancer	9.11e-06	9.07e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Capecitabine—breast cancer	9.11e-06	9.06e-05	CcSEcCtD
Temozolomide—Ill-defined disorder—Doxorubicin—breast cancer	9.06e-06	9.02e-05	CcSEcCtD
Temozolomide—Pruritus—Docetaxel—breast cancer	9.04e-06	8.99e-05	CcSEcCtD
Temozolomide—Nervous system disorder—Methotrexate—breast cancer	9.03e-06	8.98e-05	CcSEcCtD
Temozolomide—Anaemia—Doxorubicin—breast cancer	9.03e-06	8.98e-05	CcSEcCtD
Temozolomide—Thrombocytopenia—Methotrexate—breast cancer	9.01e-06	8.97e-05	CcSEcCtD
Temozolomide—Myalgia—Epirubicin—breast cancer	8.99e-06	8.94e-05	CcSEcCtD
Temozolomide—Arthralgia—Epirubicin—breast cancer	8.99e-06	8.94e-05	CcSEcCtD
Temozolomide—Agitation—Doxorubicin—breast cancer	8.98e-06	8.93e-05	CcSEcCtD
Temozolomide—Anxiety—Epirubicin—breast cancer	8.96e-06	8.91e-05	CcSEcCtD
Temozolomide—Nausea—Paclitaxel—breast cancer	8.95e-06	8.9e-05	CcSEcCtD
Temozolomide—Skin disorder—Methotrexate—breast cancer	8.94e-06	8.9e-05	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.93e-06	8.88e-05	CcSEcCtD
Temozolomide—Hyperhidrosis—Methotrexate—breast cancer	8.9e-06	8.85e-05	CcSEcCtD
Temozolomide—Discomfort—Epirubicin—breast cancer	8.88e-06	8.83e-05	CcSEcCtD
Temozolomide—Asthenia—Capecitabine—breast cancer	8.87e-06	8.83e-05	CcSEcCtD
Temozolomide—Malaise—Doxorubicin—breast cancer	8.81e-06	8.76e-05	CcSEcCtD
Temozolomide—Dry mouth—Epirubicin—breast cancer	8.79e-06	8.74e-05	CcSEcCtD
Temozolomide—Vertigo—Doxorubicin—breast cancer	8.78e-06	8.73e-05	CcSEcCtD
Temozolomide—Anorexia—Methotrexate—breast cancer	8.78e-06	8.73e-05	CcSEcCtD
Temozolomide—Pruritus—Capecitabine—breast cancer	8.75e-06	8.7e-05	CcSEcCtD
Temozolomide—Leukopenia—Doxorubicin—breast cancer	8.74e-06	8.7e-05	CcSEcCtD
Temozolomide—Diarrhoea—Docetaxel—breast cancer	8.74e-06	8.69e-05	CcSEcCtD
Temozolomide—Confusional state—Epirubicin—breast cancer	8.69e-06	8.64e-05	CcSEcCtD
Temozolomide—Palpitations—Doxorubicin—breast cancer	8.63e-06	8.59e-05	CcSEcCtD
Temozolomide—Oedema—Epirubicin—breast cancer	8.62e-06	8.57e-05	CcSEcCtD
Temozolomide—Anaphylactic shock—Epirubicin—breast cancer	8.62e-06	8.57e-05	CcSEcCtD
Temozolomide—Infection—Epirubicin—breast cancer	8.56e-06	8.51e-05	CcSEcCtD
Temozolomide—Cough—Doxorubicin—breast cancer	8.52e-06	8.48e-05	CcSEcCtD
Temozolomide—Convulsion—Doxorubicin—breast cancer	8.46e-06	8.42e-05	CcSEcCtD
Temozolomide—Diarrhoea—Capecitabine—breast cancer	8.46e-06	8.42e-05	CcSEcCtD
Temozolomide—Nervous system disorder—Epirubicin—breast cancer	8.45e-06	8.41e-05	CcSEcCtD
Temozolomide—Dizziness—Docetaxel—breast cancer	8.45e-06	8.4e-05	CcSEcCtD
Temozolomide—Thrombocytopenia—Epirubicin—breast cancer	8.44e-06	8.39e-05	CcSEcCtD
Temozolomide—Hypertension—Doxorubicin—breast cancer	8.43e-06	8.39e-05	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Methotrexate—breast cancer	8.39e-06	8.34e-05	CcSEcCtD
Temozolomide—Skin disorder—Epirubicin—breast cancer	8.37e-06	8.32e-05	CcSEcCtD
Temozolomide—Hyperhidrosis—Epirubicin—breast cancer	8.33e-06	8.29e-05	CcSEcCtD
Temozolomide—Insomnia—Methotrexate—breast cancer	8.33e-06	8.28e-05	CcSEcCtD
Temozolomide—Myalgia—Doxorubicin—breast cancer	8.32e-06	8.27e-05	CcSEcCtD
Temozolomide—Arthralgia—Doxorubicin—breast cancer	8.32e-06	8.27e-05	CcSEcCtD
Temozolomide—Anxiety—Doxorubicin—breast cancer	8.29e-06	8.24e-05	CcSEcCtD
Temozolomide—Paraesthesia—Methotrexate—breast cancer	8.27e-06	8.22e-05	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.26e-06	8.22e-05	CcSEcCtD
Temozolomide—Discomfort—Doxorubicin—breast cancer	8.22e-06	8.17e-05	CcSEcCtD
Temozolomide—Anorexia—Epirubicin—breast cancer	8.21e-06	8.17e-05	CcSEcCtD
Temozolomide—Dyspnoea—Methotrexate—breast cancer	8.21e-06	8.16e-05	CcSEcCtD
Temozolomide—Somnolence—Methotrexate—breast cancer	8.19e-06	8.14e-05	CcSEcCtD
Temozolomide—Dizziness—Capecitabine—breast cancer	8.18e-06	8.14e-05	CcSEcCtD
Temozolomide—Dry mouth—Doxorubicin—breast cancer	8.13e-06	8.09e-05	CcSEcCtD
Temozolomide—Vomiting—Docetaxel—breast cancer	8.12e-06	8.08e-05	CcSEcCtD
Temozolomide—Dyspepsia—Methotrexate—breast cancer	8.1e-06	8.06e-05	CcSEcCtD
Temozolomide—Rash—Docetaxel—breast cancer	8.05e-06	8.01e-05	CcSEcCtD
Temozolomide—Dermatitis—Docetaxel—breast cancer	8.05e-06	8e-05	CcSEcCtD
Temozolomide—Confusional state—Doxorubicin—breast cancer	8.04e-06	8e-05	CcSEcCtD
Temozolomide—Decreased appetite—Methotrexate—breast cancer	8e-06	7.96e-05	CcSEcCtD
Temozolomide—Headache—Docetaxel—breast cancer	8e-06	7.96e-05	CcSEcCtD
Temozolomide—Oedema—Doxorubicin—breast cancer	7.97e-06	7.93e-05	CcSEcCtD
Temozolomide—Anaphylactic shock—Doxorubicin—breast cancer	7.97e-06	7.93e-05	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Methotrexate—breast cancer	7.95e-06	7.91e-05	CcSEcCtD
Temozolomide—Fatigue—Methotrexate—breast cancer	7.94e-06	7.9e-05	CcSEcCtD
Temozolomide—Infection—Doxorubicin—breast cancer	7.92e-06	7.88e-05	CcSEcCtD
Temozolomide—Pain—Methotrexate—breast cancer	7.87e-06	7.83e-05	CcSEcCtD
Temozolomide—Vomiting—Capecitabine—breast cancer	7.86e-06	7.82e-05	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Epirubicin—breast cancer	7.85e-06	7.81e-05	CcSEcCtD
Temozolomide—Nervous system disorder—Doxorubicin—breast cancer	7.82e-06	7.78e-05	CcSEcCtD
Temozolomide—Thrombocytopenia—Doxorubicin—breast cancer	7.81e-06	7.76e-05	CcSEcCtD
Temozolomide—Rash—Capecitabine—breast cancer	7.8e-06	7.76e-05	CcSEcCtD
Temozolomide—Insomnia—Epirubicin—breast cancer	7.79e-06	7.75e-05	CcSEcCtD
Temozolomide—Dermatitis—Capecitabine—breast cancer	7.79e-06	7.75e-05	CcSEcCtD
Temozolomide—Headache—Capecitabine—breast cancer	7.75e-06	7.71e-05	CcSEcCtD
Temozolomide—Skin disorder—Doxorubicin—breast cancer	7.74e-06	7.7e-05	CcSEcCtD
Temozolomide—Paraesthesia—Epirubicin—breast cancer	7.74e-06	7.7e-05	CcSEcCtD
Temozolomide—Hyperhidrosis—Doxorubicin—breast cancer	7.71e-06	7.67e-05	CcSEcCtD
Temozolomide—Dyspnoea—Epirubicin—breast cancer	7.68e-06	7.64e-05	CcSEcCtD
Temozolomide—Somnolence—Epirubicin—breast cancer	7.66e-06	7.62e-05	CcSEcCtD
Temozolomide—Anorexia—Doxorubicin—breast cancer	7.6e-06	7.56e-05	CcSEcCtD
Temozolomide—Nausea—Docetaxel—breast cancer	7.59e-06	7.55e-05	CcSEcCtD
Temozolomide—Feeling abnormal—Methotrexate—breast cancer	7.59e-06	7.55e-05	CcSEcCtD
Temozolomide—Dyspepsia—Epirubicin—breast cancer	7.58e-06	7.54e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Methotrexate—breast cancer	7.53e-06	7.49e-05	CcSEcCtD
Temozolomide—Decreased appetite—Epirubicin—breast cancer	7.49e-06	7.45e-05	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Epirubicin—breast cancer	7.44e-06	7.4e-05	CcSEcCtD
Temozolomide—Fatigue—Epirubicin—breast cancer	7.43e-06	7.39e-05	CcSEcCtD
Temozolomide—Pain—Epirubicin—breast cancer	7.37e-06	7.33e-05	CcSEcCtD
Temozolomide—Constipation—Epirubicin—breast cancer	7.37e-06	7.33e-05	CcSEcCtD
Temozolomide—Nausea—Capecitabine—breast cancer	7.35e-06	7.31e-05	CcSEcCtD
Temozolomide—Urticaria—Methotrexate—breast cancer	7.31e-06	7.28e-05	CcSEcCtD
Temozolomide—Body temperature increased—Methotrexate—breast cancer	7.28e-06	7.24e-05	CcSEcCtD
Temozolomide—Abdominal pain—Methotrexate—breast cancer	7.28e-06	7.24e-05	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.26e-06	7.23e-05	CcSEcCtD
Temozolomide—Insomnia—Doxorubicin—breast cancer	7.21e-06	7.17e-05	CcSEcCtD
Temozolomide—Paraesthesia—Doxorubicin—breast cancer	7.16e-06	7.12e-05	CcSEcCtD
Temozolomide—Dyspnoea—Doxorubicin—breast cancer	7.11e-06	7.07e-05	CcSEcCtD
Temozolomide—Feeling abnormal—Epirubicin—breast cancer	7.1e-06	7.06e-05	CcSEcCtD
Temozolomide—Somnolence—Doxorubicin—breast cancer	7.09e-06	7.05e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Epirubicin—breast cancer	7.05e-06	7.01e-05	CcSEcCtD
Temozolomide—Dyspepsia—Doxorubicin—breast cancer	7.02e-06	6.98e-05	CcSEcCtD
Temozolomide—Decreased appetite—Doxorubicin—breast cancer	6.93e-06	6.89e-05	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Doxorubicin—breast cancer	6.88e-06	6.85e-05	CcSEcCtD
Temozolomide—Fatigue—Doxorubicin—breast cancer	6.87e-06	6.84e-05	CcSEcCtD
Temozolomide—Urticaria—Epirubicin—breast cancer	6.84e-06	6.81e-05	CcSEcCtD
Temozolomide—Constipation—Doxorubicin—breast cancer	6.82e-06	6.78e-05	CcSEcCtD
Temozolomide—Pain—Doxorubicin—breast cancer	6.82e-06	6.78e-05	CcSEcCtD
Temozolomide—Body temperature increased—Epirubicin—breast cancer	6.81e-06	6.78e-05	CcSEcCtD
Temozolomide—Abdominal pain—Epirubicin—breast cancer	6.81e-06	6.78e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Methotrexate—breast cancer	6.78e-06	6.75e-05	CcSEcCtD
Temozolomide—Asthenia—Methotrexate—breast cancer	6.61e-06	6.57e-05	CcSEcCtD
Temozolomide—Feeling abnormal—Doxorubicin—breast cancer	6.57e-06	6.53e-05	CcSEcCtD
Temozolomide—Gastrointestinal pain—Doxorubicin—breast cancer	6.52e-06	6.48e-05	CcSEcCtD
Temozolomide—Pruritus—Methotrexate—breast cancer	6.51e-06	6.48e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Epirubicin—breast cancer	6.35e-06	6.31e-05	CcSEcCtD
Temozolomide—Urticaria—Doxorubicin—breast cancer	6.33e-06	6.3e-05	CcSEcCtD
Temozolomide—Abdominal pain—Doxorubicin—breast cancer	6.3e-06	6.27e-05	CcSEcCtD
Temozolomide—Body temperature increased—Doxorubicin—breast cancer	6.3e-06	6.27e-05	CcSEcCtD
Temozolomide—Diarrhoea—Methotrexate—breast cancer	6.3e-06	6.27e-05	CcSEcCtD
Temozolomide—Asthenia—Epirubicin—breast cancer	6.18e-06	6.15e-05	CcSEcCtD
Temozolomide—Pruritus—Epirubicin—breast cancer	6.1e-06	6.06e-05	CcSEcCtD
Temozolomide—Dizziness—Methotrexate—breast cancer	6.09e-06	6.06e-05	CcSEcCtD
Temozolomide—Diarrhoea—Epirubicin—breast cancer	5.9e-06	5.86e-05	CcSEcCtD
Temozolomide—Hypersensitivity—Doxorubicin—breast cancer	5.87e-06	5.84e-05	CcSEcCtD
Temozolomide—Vomiting—Methotrexate—breast cancer	5.85e-06	5.82e-05	CcSEcCtD
Temozolomide—Rash—Methotrexate—breast cancer	5.81e-06	5.77e-05	CcSEcCtD
Temozolomide—Dermatitis—Methotrexate—breast cancer	5.8e-06	5.77e-05	CcSEcCtD
Temozolomide—Headache—Methotrexate—breast cancer	5.77e-06	5.74e-05	CcSEcCtD
Temozolomide—Asthenia—Doxorubicin—breast cancer	5.72e-06	5.69e-05	CcSEcCtD
Temozolomide—Dizziness—Epirubicin—breast cancer	5.7e-06	5.67e-05	CcSEcCtD
Temozolomide—Pruritus—Doxorubicin—breast cancer	5.64e-06	5.61e-05	CcSEcCtD
Temozolomide—Vomiting—Epirubicin—breast cancer	5.48e-06	5.45e-05	CcSEcCtD
Temozolomide—Nausea—Methotrexate—breast cancer	5.47e-06	5.44e-05	CcSEcCtD
Temozolomide—Diarrhoea—Doxorubicin—breast cancer	5.45e-06	5.43e-05	CcSEcCtD
Temozolomide—Rash—Epirubicin—breast cancer	5.43e-06	5.4e-05	CcSEcCtD
Temozolomide—Dermatitis—Epirubicin—breast cancer	5.43e-06	5.4e-05	CcSEcCtD
Temozolomide—Headache—Epirubicin—breast cancer	5.4e-06	5.37e-05	CcSEcCtD
Temozolomide—Dizziness—Doxorubicin—breast cancer	5.27e-06	5.24e-05	CcSEcCtD
Temozolomide—Nausea—Epirubicin—breast cancer	5.12e-06	5.09e-05	CcSEcCtD
Temozolomide—Vomiting—Doxorubicin—breast cancer	5.07e-06	5.04e-05	CcSEcCtD
Temozolomide—Rash—Doxorubicin—breast cancer	5.03e-06	5e-05	CcSEcCtD
Temozolomide—Dermatitis—Doxorubicin—breast cancer	5.02e-06	5e-05	CcSEcCtD
Temozolomide—Headache—Doxorubicin—breast cancer	4.99e-06	4.97e-05	CcSEcCtD
Temozolomide—Nausea—Doxorubicin—breast cancer	4.74e-06	4.71e-05	CcSEcCtD
